EZEM nearly doubled recently apparently due to a report that the government is testing a decontamination lotion from ezem. I guess its expected that anytime a small cap is mentioned in the same breath as anthrax treatment there is bound to be an unjustified run up in price. I don't know if I would buy at $9/share but this stock was a steal when it was trading around $5/share. Angiodynamics subsidiary is growing like mad and could be spun off once it achieves sufficient stability. Just my thoughts on this lonely board :)
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra